Morningside Venture Partners logo

Morningside Venture Partners

North America, New York, United States, New York

Description

Morningside Venture Partners focuses on partnering with talented entrepreneurs to develop the next wave of truly great companies.

Investor Profile

Morningside Venture Partners has made 19 investments, with 0 in the past 12 months and 16% as lead.

Stage Focus

  • Series Unknown (32%)
  • Series B (16%)
  • Seed (16%)
  • Series A (16%)
  • Series C (11%)
  • Series D (5%)
  • Angel (5%)

Country Focus

  • United States (37%)
  • China (26%)
  • United Kingdom (26%)
  • Brazil (5%)
  • Israel (5%)

Industry Focus

  • Biotechnology
  • Medical
  • Therapeutics
  • Health Care
  • Saas
  • Life Science
  • Internet
  • Advertising
  • Artificial Intelligence (Ai)
  • Machine Learning
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Morningside Venture Partners frequently co-invest with?

Golden Ventures
North America, Ontario, Canada, Toronto
Co-Investments: 2
Shunwei Capital
Asia, Beijing, China, Beijing
Co-Investments: 3
CA
North America, Massachusetts, United States, Boston
Co-Investments: 2
IDG Capital
Asia, Beijing, China, Beijing
Co-Investments: 4
General Catalyst
North America, Massachusetts, United States, Cambridge
Co-Investments: 2
Visible Ventures
North America, Massachusetts, United States, Boston
Co-Investments: 2
Boston Seed Capital
North America, Massachusetts, United States, Boston
Co-Investments: 2
PI
North America, Georgia, United States, Germany
Co-Investments: 3
Alumni Ventures
North America, New Hampshire, United States, Manchester
Co-Investments: 2
Manifest
North America, California, United States, Belvedere Tiburon
Co-Investments: 2

Which angels does Morningside Venture Partners often collaborate with?

AM
North America, United States
Shared Deals: 1
Xiaopeng He
Asia, Guangdong, China, Guangzhou
Shared Deals: 1
KH
North America, New York, United States, New York
Shared Deals: 1
David Wadler
North America, New York, United States, New York
Shared Deals: 1

What are some of recent deals done by Morningside Venture Partners?

AGORAB2B

São Paulo, Sao Paulo, Brazil

POWERFUL platform for B2B e-commerce and sourcing

B2BE-CommerceE-Commerce PlatformsProcurementSaaS
SeedOct 17, 2023
Amount Raised: $70,000
CellCentric

Cambridge, Cambridgeshire, United Kingdom

CellCentric is a biotechnology company that targets at deubiquitinase (DUB) enzyme for cancer therapy.

BiotechnologyMedicalTherapeutics
Series UnknownJan 26, 2022
Prilenia

Herzliya, Tel Aviv, Israel

Prilenia is a clinical-stage biotech company that develops novel treatments for neurodegenerative and neurodevelopmental disorders.

BiotechnologyHealth CareLife SciencePharmaceutical
Series BNov 3, 2021
Amount Raised: $43,000,000
Alyce

Framingham, Massachusetts, United States

Alyce is an AI-powered Personal Experience Platform empowers marketers and sellers to build bonds with their prospects & customers at scale.

AdvertisingArtificial Intelligence (AI)Machine LearningSaaSSoftware
Series BApr 8, 2021
Amount Raised: $30,000,000
Gracell Biotechnologies

Suzhou, Jiangsu, China

Gracell Biotechnologies is a developer of cancer immune therapy designed to treat cancer.

BiotechnologyHealth CareMedical
Series COct 28, 2020
Amount Raised: $100,000,000
VaxEquity

Cambridge, Massachusetts, United States

VaxEquity is a biotechnology company that develops RNA therapeutics and vaccines.

BiotechnologyMedicalTherapeutics
SeedJun 17, 2020
Greenlight Biosciences

Medford, Massachusetts, United States

GreenLight Biosciences is a biotechnology company that develops an RNA platform for agriculture and human health.

AgricultureAgTechBiotechnologyLife Science
Series DJun 16, 2020
Amount Raised: $102,000,000
Alyce

Framingham, Massachusetts, United States

Alyce is an AI-powered Personal Experience Platform empowers marketers and sellers to build bonds with their prospects & customers at scale.

AdvertisingArtificial Intelligence (AI)Machine LearningSaaSSoftware
Series AJun 10, 2019
Amount Raised: $11,500,000
Epivax Oncology

Providence, Rhode Island, United States

Epivax Oncology is a providence, RI and NY-based precision cancer immunotherapy company.

BiotechnologyHealth CareHospitalOncology
Series UnknownJun 12, 2018
Amount Raised: $1,200,000
CellCentric

Cambridge, Cambridgeshire, United Kingdom

CellCentric is a biotechnology company that targets at deubiquitinase (DUB) enzyme for cancer therapy.

BiotechnologyMedicalTherapeutics
Series UnknownMay 15, 2018
Amount Raised: $26,000,000